Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes
Open Access
- 16 July 2015
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 16 (7) , 16176-16215
Abstract
Ewing sarcoma is an aggressive neoplasm occurring predominantly in adolescent Caucasians. At the genome level, a pathognomonic EWSR1-ETS translocation is present. The resulting fusion protein acts as a molecular driver in the tumor development and interferes, amongst others, with endogenous transcription and splicing. The Ewing sarcoma cell shows a poorly differentiated, stem-cell like phenotype. Consequently, the cellular origin of Ewing sarcoma is still a hot discussed topic. To further characterize Ewing sarcoma and to further elucidate the role of EWSR1-ETS fusion protein multiple genome, epigenome and transcriptome level studies were performed. In this review, the data from these studies were combined into a comprehensive overview. Presently, classical morphological predictive markers are used in the clinic and the therapy is dominantly based on systemic chemotherapy in combination with surgical interventions. Using sequencing, novel predictive markers and candidates for immuno- and targeted therapy were identified which were summarized in this review.Keywords
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-TOP GO 854.10.012)
This publication has 229 references indexed in Scilit:
- Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicityCancer Immunology, Immunotherapy, 2013
- DNA Methylation Profile Distinguishes Clear Cell Sarcoma of the Kidney from Other Pediatric Renal TumorsPLOS ONE, 2013
- EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populationsCancer Genetics, 2012
- A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionNature Genetics, 2012
- CAPER‐α alternative splicing regulates the expression of vascular endothelial growth factor165 in Ewing sarcoma cellsCancer, 2011
- Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cellsBritish Journal of Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of TumorsInternational Journal of Cancer, 2010
- Angiogenesis and vascular targeting in Ewing sarcomaCancer, 2009
- Stromal cell‐derived factor‐1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factorInternational Journal of Cancer, 2008